Genizon BioSciences Inc. Licenses Crohn's Disease GeneMap To Genentech, Inc.; Results Of Whole Genome Association Study To Be Used To Support Development Of New Therapeutics And Diagnostics
MONTREAL, August 8 /CNW/ - Genizon BioSciences today announced a license
and collaboration agreement with Genentech, Inc. (NYSE:DNA) of South San
Francisco, Calif. Genizon grants Genentech an exclusive license to Genizon's
GeneMap of disease-associated genes generated from a whole genome association
study of Crohn's disease patients from the Quebec Founder Population.